StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Caspofungin Acetate

HCID 6850808
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
179463-17-3
Standard-SMILES
CC(=O)O.CC(=O)O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O
InChIKey
OGUJBRYAAJYXQP-LLXMLGLCSA-N
Summenformel
C56H96N10O19
Durchschnittliche Molmasse
1.213,4 g/mol

Überblick

Caspofungin Acetate is the acetate salt of an antimycotic echinocandin lipopeptide, semisynthetically derived from a fermentation product of the fungus Glarea lozoyensis. Caspofungin inhibits 1,3-beta-glucan synthase, resulting in decreased synthesis of beta(1,3)-D-glucan (an essential component of the fungal cell wall), weakening of the fungal cell wall, and fungal cell wall rupture. This agent is active against Aspergillus and Candida species.

Namen und Bezeichner

Bevorzugter Name
Caspofungin Acetate
IUPAC
acetic acid;N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
Englischer Name
Caspofungin acetate
Summenformel
C54H92N10O17
Molmasse
1153.38

Namen und Synonyme

Caspofungin acetate179463-17-3caspofungin diacetateCHEBI:59900DTXSID60904590RefChem:56793DTXCID801333717VUW370O5QECancidasMFCD08141839Caspofungin Acetate (>90%)C56H96N10O19
Weitere Namen anzeigen
(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-Aminoethylamino)-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxyethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,13)]heptacosane-2,5,8,14,17,23-hexaone diacetateMk0991Mk 0991L 743872L-743872L 743873L 743,872L-743,872
Caspofungin acetate (JAN/USAN)AC-27763D02501MK-0991 (Acetate);L-743872 (Acetate)SCHEMBL149293AKOS025401982FC16269Caspofungin acetate - Bio-X trade mark

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
487 Ų
H-Brücken-Donoren
18
H-Brücken-Akzeptoren
22
Frei drehbare Bindungen
23
Schwere Atome
85
Formalladung
0
Komplexität
1.930

Experimentelle und physikochemische Eigenschaften

Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Schmelzpunkt
105 °C · >105°C (dec.)
storage temp.
-20 °C · -20°C
Löslichkeit
2 O: · H2O: soluble15mg/mL (clear solution)
Aggregatzustand
powder
Farbe
white to beige
Wasserlöslichkeit
2 O: · H2O: 15mg/mL (clear solution)
InChIKey
OGUJBRYAAJYXQP-LLXMLGLCSA-N

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H318 (93%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

P203, P260, P263, P264, P264+P265, P270, P273, P280, P305+P354+P338, P317, P318, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesEye Dam. 1 (93%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Caspofungin acetate

Ambiguous-DILI-concern

7

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
RTECS-Nr.
TP8046500
Speicherklasse
11 - Combustible Solids

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 2 Einträge

CASPOFUNGIN ACETATE

Lipopeptides [CS]; Echinocandin Antifungal [EPC]

MeSH Pharmacological Classification · 2 Einträge

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Verwendung und Herstellung

UsesUse (kg) in USA (2002): 5
Anwendungen · 2 Einträge

BeschreibungCaspofungin is the first in a new class of antifungal agents named echinocandin to be launched in the US for the parenteral treatment of invasive aspergillosis in patients refractory to, or intolerant of other antifungal therapies such as amphotericin-B1 lipid formulation of amphotericin-B and/or itraconazole. Caspofungin is a water soluble, stable, aza-substituted semisynthetic derivative of pneumocandin B, a fermentation product of the fungus Zalerion arboricola. Since fungi and humans are both eukaryotes, new antifungal agents must focus on fungus-specific targets in order to minimize potential toxicity in the human host. In this respect, the lipopeptide caspofungin, inhibits the synthesis of 1,3-beta- D-glucans present only in the fungal cell wall, which leads to the specific lysis of the pathogenic cells. The compound is fungicidal rather than fungistatic, an unusual feature among antifungal agents. Caspofungin has activity in vitro and in vivo against a range of Candida species (including azole and amphotericin B resistant Candida) and also against Aspergillus, an important pathogen which is not susceptible to fluconazole. Caspofungin was generally more active than amphotericin B, flucytosine, fluconazole and itraconazole against Candida species. Cryptococcus is not susceptible to caspofungin. Caspofungin has a half-life in human beings around 10 hours. Unlike the azoles, caspofungin does not inhibit cytochrome P450. The drug has been given intravenously with loading dose of 70 rag, followed by 50 mg daily to be effective in invasive aspergillosis refractory to prior antifungal therapy. Most of the side effects were mild and comprised fever, thrombophlebitis, headache, nausea, rash and flushing.

Zugehörige Reaktionen

4
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1404677
HRID 1404677als Produkt
Reaktionsgleichung von HRID 1404678
HRID 1404678als Produkt
Reaktionsgleichung von HRID 1404679
HRID 1404679als Produkt
Reaktionsgleichung von HRID 2173738
HRID 2173738als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
179463-17-3
PubChem CID
6850808
ChEMBL
CHEMBL5314378
EC Number
605-859-0

VerwendenCaspofungin Diacetate is an impurity of Caspofungin Acetate(C184900) which is an echinocandin that inhibits the synthesis of β (1,3)-D-glucan, an integral component of the fungal cell wall. An antifungal drug used in the treatment of invasive fungal infections.

Ergänzende Hinweise

DefinitionChEBI: The diacetate salt of caspofungin. It is used for the treatment of invasive candidiasis, and of aspergillosis in patients who are refractory to, or intolerant of, other therapy.